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Background: An infected total knee arthroplasty (TKA) can be treated with irrigation
and débridement with polyethylene exchange (IDPE) or a 2-staged revision (2SR).
Although research has examined infection eradication rates of both treatments, patient
outcomes have not been reported. We examined patient-reported outcomes following
treatment compared with matched, noninfected controls.
Methods: We retrospectively identified patients with infected TKAs who had undergone
the index procedure between May 1991 and November 2011. Patient-reported outcomes
included the 12-item Short Form Health Survey, Western Ontario and McMaster Universities Arthritis Index, and Knee Society Scores as well as range of motion. Patients with
noninfected primary TKAs matched by age and age-adjusted Charlson Comorbidity
Index score were used as controls. Intention-to-treat groups of 2SR and IDPE were used,
with the IDPE group subdivided into successful and unsuccessful groups.
Results: We included 145 patients with infected TKAs with mean follow-up of
64.2 months and 145 controls with a mean follow-up of 35.4 months in our analysis. Outcomes of the controls and the successful IDPE groups were equivalent. The 2SR cohort
had lower scores in all categories than controls. There was a 39% success rate in eradicating infection with IDPE. Patients in whom IDPE failed had lower scores in all categories
than controls. There was no difference between the failed IDPE group and the 2SR group.
Conclusion: Controversy regarding treatment options for acutely infected TKA has
been focused on infection eradication. However, functional outcomes following treatment need to be taken into consideration. Patients whose infections were successfully
treated with IDPE had equivalent outcomes to controls.
Contexte : Il est possible de traiter une arthroplastie totale du genou (ATG) infectée par
irrigation et débridement avec changement du polyéthylène (IDCP) ou par une révision
en 2 étapes. Même si la recherche a examiné les taux d’éradication de l’infection au
moyen des 2 traitements, les résultats chez les patients n’ont pas fait l’objet de rapports.
Nous avons comparé les résultats enregistrés chez les patients traités à ceux de témoins
assortis non infectés.
Méthodes : Nous avons recensé de manière rétrospective les patients qui ont présenté
une infection de leur ATG et qui avaient initialement subi leur intervention entre mai
1991 et novembre 2011. Les résultats rapportés par les patients incluaient le questionnaire
SF (Short Form) sur la santé en 12 points, l’indice WOMAC (établi par les universités
Western Ontario et McMaster), le score de la Knee Society, de même que l’amplitude de
mouvement. Des patients soumis à une ATG primaire non infectée assortis selon l’âge et
le score de comorbidités de Charlson ajusté selon l’âge ont servi de participants témoins.
On a réparti les groupes selon l’intention de traiter par révision en 2 étapes ou par IDCP;
le groupe IDCP a été subdivisé selon que l’intervention avait réussi ou non.
Résultats : Notre analyse a regroupé 145 patients dont l’ATG s’était infectée et qui ont
été suivis en moyenne pendant 64,2 mois, et 145 témoins suivis en moyenne pendant
35,4 mois. Les résultats ont été équivalents chez les témoins et les groupes dont l’IDCP
avait réussi. La cohorte soumise à la révision en 2 étapes a obtenu des scores moindres
dans toutes les catégories, comparativement aux témoins. On a noté un taux de succès de
39 % pour l’éradication de l’infection avec l’IDCP. Les patients chez qui l’IDCP a
échoué présentaient des scores moindres dans toutes les catégories comparativement aux
témoins. On n’a noté aucune différence entre le groupe chez qui l’IDCP avait échoué et
le groupe soumis à la révision en 2 étapes.
Conclusion : La controverse quant aux options thérapeutiques pour les infections aiguës
d’ATG portait sur l’éradication de l’infection. Or, les résultats fonctionnels après le traitement devraient aussi entrer en ligne de compte. Chez les patients dont les infections ont
été traitées avec succès par IDCP, les résultats ont été équivalents à ceux des témoins.

402

acute-dzaja.indd 402

o

J can chir, Vol. 58, N 6, décembre 2015

©2015 8872147 Canada Inc.

2015-11-10 9:53 AM

RESEARCH

P

eriprosthetic joint infection is a devastating complication after total knee arthroplasty (TKA). Between
2005 and 2006, 25% of revisions were to manage
infection.1 Demand for primary TKA in the United States
is projected to grow by 673% to 3.48 million procedures
by 2030.2 This would translate into a huge number of
patients experiencing periprosthetic joint infections, with
the care of these patients representing a substantial financial burden to society. The surgical options for treatment
of periprosthetic infection include irrigation and débridement with polyethylene exchange (IDPE), single-stage
revision, or 2-stage revision (2SR).
Irrigation and débridement with polyethylene exchange
is an attractive alternative for both patient and surgeon.
Compared with a 2SR, benefits of an IDPE include retention of implants, preservation of bone stock, shorter procedure duration, less chance of intraoperative fracture
from removal of components and implantation of cement
spacers, and faster postoperative rehabilitation.3–5 However, the reported success rate of IDPE is variable, with
reports ranging from 29% to 83%.6–10 By comparison,
2SR is considered the gold standard, with success rates
reported in the range of 75%–100%.11–17 In addition, it
has been reported that failure rates of 2SR for TKA infections are higher in patients treated with previous IDPE
than in patients who did not receive IDPE.18 Therefore,
surgeons considering IDPE need to balance potential
benefits of the procedure with the lower eradication rate
and potentially decreased chance of eradication should the
patient ultimately receive 2SR.
There may be a role for IDPE in certain situations, such
as the treatment of acute postoperative and acute hemato
genous infections.19 An acute postoperative infection has
been defined as one that occurs within the first 4 weeks after
index TKA.20 Other studies are more reserved in their recommendations and state that IDPE should be considered
only in immunologically optimized patients with acute nonStaphylococcal infections.21 Although there is an abundance
of literature studying the successful eradication rates with
IDPE and 2SR, there is a paucity of data reporting on the
patient experience or patient satisfaction associated with
these revision procedures. Understanding patient-reported
satisfaction is important to the treatment decision process.
Therefore, the purpose of this study was to examine patientreported outcomes in patients with infected TKAs based on
whether the patients were treated with initial 2SR, successful
IDPE, or failed IDPE with subsequent 2SR; to compare
each of the above cohorts to a matched control group of
patients with noninfected TKAs; and to determine the success rates of 2SR and IDPE in our study population.

Methods
After obtaining institutional review board approval, we
performed a database query to identify patients whose

index TKAs, performed between May 1991 and November 2011, were acutely infected. Inclusion criteria for our
retrospective review were a minimum 1-year follow-up
after surgical treatment of infection.
All procedures were performed by 1 of 7 surgeons at
our institution. All 7 are high-volume, arthroplasty
fellowship–trained surgeons. Implant type for the index
procedures included varying levels of constraint, including posterior stabilized, varus-valgus constrained nonhinged, and hinged knees.
In 2011, The Musculoskeletal Infection Society created
guidelines for the diagnosis of periprosthetic joint infection
(PJI). A definite diagnosis of PJI can be made when the following conditions are met.22
• Sinus tract communicating with the prosthesis.
• Pathogen isolated by culture from 2 separate tissue or fluid samples obtained from the affected
prosthetic joint.
• Presence of at least 4 of the following: elevated
serum erythrocyte sedimentation rate (ESR) or
serum C-reactive protein (CRP) concentration,
elevated synovial white blood cell count, elevated
synovial neutrophil percentage, presence of purulence in the affected joint, isolation of a micro
organism in 1 culture of periprosthetic tissue or
fluid, and more than 5 neutrophils per highpower field in 5 high-power fields observed from
histologic analysis of periprosthetic tissue at ×400
magnification.
At our institution, diagnosis of infection follows these
criteria, with the whole clinical picture used to guide
treatment. Threshold values for ESR and CRP in the
present study were are 30 mm/hr and 10 mg/L, respect
ively. We excluded patients with less than 1 year of complete follow-up.
Identified patients were matched to a control cohort
of patients with noninfected primary TKAs based on
age and the age-adjusted Charlson Comorbidity Index
(CCI) score. The CCI score is a validated method of
estimating risk of death from comorbid disease and has
also been found to correlate well with major complications in revision surgery.23,24 Patients with a surgically
managed infected TKA were then divided into either
the 2SR or IDPE group based on intention to treat. The
type of treatment performed was at the discretion of the
treating surgeon. The IDPE group was then further
subdivided based on whether the IDPE was successful
or unsuccessful at eradicating infection; patients in
whom IDPE was not successful required subsequent
2SR. Both acute hematogenous and acute postoperative
infections were defined as those presenting within
4 weeks of onset of symptoms. We considered the infection to be eradicated when the inflammatory markers
had normalized, the clinical symptoms had improved
and the surgical wound had healed.
Can J Surg, Vol. 58, No. 6, December 2015
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Functional outcomes and reoperations associated with
unsuccessful eradication of infection were reviewed. We
used the most recent patient-reported scores and range
of motion (ROM) for analysis. For patients who had
unsuccessful IDPE and required subsequent 2SR, clinical
outcomes were measured at their most recent follow-up
(i.e., after their 2SR). We calculated CCI scores based on
a review of patient charts. At each clinic visit, ROM was
recorded using a goniometer; ROM at the initial visit
and at latest review was used in this study. Western
Ontario and McMaster Universities Arthritis Index
(WOMAC), Knee Society Clinical Rating System (KSS)
and the 12-item Short-Form Health Survey (SF12)
scores were recorded from standardized forms that are
routinely used for all arthroplasty patients at our institution. All 3 scores have been validated for use in quantifying knee pain and function.25–27
Statistical analysis
We used the Statistical Package for the Social Sciences
(SPSS Inc.) for the statistical analysis. We used the Student t test for parametric comparisons and the Mann–
Whitney U test for nonparametric comparisons between
the groups. The Mann–Whitney U test was used when
data for a particular variable did not meet the distribution
assumptions required by their parametric counterpart.

Results
During our study period, 1857 knee revisions were performed at our institution. Review of our database identi-

fied 145 infected TKAs in 145 patients. Of the
145 patients with infected TKAs, 91 were treated initially
with 2SR and 54 were treated with IDPE. Of the
91 patients treated with 2SR, 79 had successful eradication
of infection and 12 had reoperations for infection. Of the
54 patients treated with IDPE, 21 had successful infection
eradication and 33 had a persistent infection and required
2SR (Fig. 1). All of the patients in our cohort in whom
IDPE failed received a subsequent 2SR. Of the 21 patients
in whom IDPE was successful, 9 had their infections diagnosed during the acute postoperative period and 12 had
diagnoses of acute hematogenous infection. Of the
33 patients in whom IDPE was unsuccessful, 4 had their
infections diagnosed during the acute postoperative
period and 29 patients had diagnoses of acute hemato
genous infection (Fig. 1). In other words, acute postoperative infection in our patient cohort represented 43% of
successful IDPE and 12% of failed IDPE.
There was no difference in age, CCI scores or body mass
index between controls and patients with infected TKAs
(Table 1). Mean clinical follow-up for patients with infected
TKAs was 64.2 (range 12–237) months compared with 35.4
(range 24–120) months in the control group (p < 0.001;
Table 1).
For the successful IDPE cohort, 6.7% of patients had a
hinged prosthesis and 93.3% had posterior stabilized prostheses. All patients in the failed IDPE group had posterior
stabilized prostheses. In the 2SR group, 6.1% had a hinged
prosthesis, 57.3% had varus-valgus constrained prostheses,
and 36.6% had posterior stabilized prostheses. The mean
duration from initial arthroplasty surgery to the 2SR was
31.7 (range 2–180) months. The mean duration from initial

145
total infected
patients

91 2SR
patients

21 successful
IDPE patients

9 acute
postoperative
infections

12 acute
hematogenous
infections

54 IDPE
patients

33 unsuccessful
IDPE patients

4 acute
postoperative
infections

29 acute
hematogenous
infections

Fig. 1. Distribution of patients based on treatment algorithm. 2SR = 2-staged revision; IDPE = irrigation
and débridement with polyethylene exchange.
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arthroplasty to successful IDPE was 15.3 (range 1–89)
months. Finally, the mean duration from initial arthroplasty
to failed IDPE was 23.8 (range 1–120) months.
Compared with the 2SR group, the control group performed better on all measures, with better SF12 mental
composite scale (p = 0.005), SF12 physical composite scale
(p = 0.002), WOMAC (p < 0.001) and KSS (p < 0.001)
scores and improved ROM (p < 0.001) at latest review
(Table 2). When the 2SR group was divided into successful and failed 2SR, the control group performed better
than both on all measured outcomes (all p < 0.05). Similarly, the control group performed better on all measures
than the failed IDPE group (all p < 0.05; Table 3). Comparing the failed IDPE group with the 2SR group revealed
no difference in any outcome (all p > 0.05; Table 4). Comparing the control group with the successful IDPE group
demonstrated no difference in any measured outcome (all
p > 0.05; Table 5). The success rate with IDPE was 39%
and the success rate with 2SR was 87% in our cohorts.
Table 1. Patient demographic and clinical characteristics
Group; mean
Characteristic

Control

Infection

p value

Age, yr

67.7

68.9

0.21

CCI score

1.51

1.65

0.49

BMI

32.8

33.1

0.84

Follow-up, mo

35.4

64.2

< 0.001

BMI = body mass index; CCI = Charlson Comorbidity Index.

Table 2. Outcome scores comparing controls with patients
with infected TKAs who received a 2SR

Control

2SR

p value

SF12 mental component score

53.4

49.7

0.045

SF12 physical component score

38.9

33.8

0.002

KSS

169.3

135.3

< 0.001

WOMAC

78.1

62.8

< 0.001

ROM, arc

116.9

91.1

< 0.001

2SR = 2-staged revision; KSS = Knee Society score; ROM = range of motion; SF12 =
12-item Short Form Health Survey; TKA = total knee arthroplasty; WOMAC = Western
Ontario and McMaster Universities Arthritis Index.

Table 3. Outcome scores comparing controls with patients
with infected TKAs in whom IDPE failed
Group; mean
Outcome measure
SF12 mental component score

Periprosthetic joint infection continues to be a challenge in
TKA for both patients and surgeons. Twenty-fice percent
of revisions are done as a result of infection,1 with an incidence rate of 1% for TKA.28 The optimal treatment for
patients with infected TKAs is controversial. While 2SR
remains the gold standard in treatment with an eradication
rate ranging from 75% to 100%,11–17 there is no clear consensus on the role of IDPE in the treatment of periprosthetic infection. Compared with 2SR, the benefits of IDPE
include retention of implants with preservation of bone
stock, shorter procedure durations, decreased chance of
intraoperative fracture from removal of components with
implantation of cement spacers, and faster postoperative
rehabilitation.3–5 The main arguments against the use of
IDPE as a treatment option have centered on its low success rate at eradicating infection and on the possibility that
IDPE may reduce the success rate of a subsequent 2SR.18
There is an abundance of literature on the treatment of an
infected TKA with success rates of IDPE reported to
range from 29% to 83%.6–10 Therefore, we elected not to
focus on success or failure rates of eradication. Instead, the
aim of the present study was to add to the body of literature by being, to our knowledge, the first study to focus on
patient-reported outcomes based on treatment provided.
Our results demonstrate that there is no difference in
patient-reported clinical outcomes when comparing
Table 4. Outcome scores comparing failed IDPE with 2SR
Group; mean
Outcome measure

Group; mean
Outcome measure

Discussion

Control

Failed IDPE

p value

53

46.1

0.026

SF12 physical component score

42.5

37.3

0.045

KSS

170.4

142.1

0.004

WOMAC

76.2

63.9

0.036

ROM, arc

116.6

93.6

0.003

IDPE = irrigation and débridement with polyethylene exchange; KSS = Knee Society
score; ROM = range of motion; SF12 = 12-item Short Form Health Survey; TKA = total
knee arthroplasty; WOMAC = Western Ontario and McMaster Universities Arthritis Index.

Failed IDPE

2SR

p value

SF12 mental component score

45.2

49.7

0.08

SF12 physical component score

37.2

33.8

0.12

KSS

141.8

135.3

0.54

WOMAC

63.9

62.8

0.93

ROM, arc

93.4

91.1

0.47

2SR = 2-staged revision; IDPE = irrigation and débridement with polyethylene exchange;
KSS = Knee Society score; ROM = range of motion; SF12 = 12-item Short Form Health
Survey; TKA = total knee arthroplasty; WOMAC = Western Ontario and McMaster
Universities Arthritis Index.

Table 5. Outcomes comparing controls with patients with
infected TKAs in whom IDPE was successful
Group; mean
Outcome measure

Control

Successful IDPE

p value

SF12 mental component score

49.4

50.1

0.96

SF12 physical component score

37.2

37.7

0.93

KSS

160.8

150.1

0.48

WOMAC

75.6

72.1

0.67

ROM, arc

109

110.9

0.56

2SR = 2-staged revision; IDPE = irrigation and débridement with polyethylene exchange;
KSS = Knee Society score; ROM = range of motion; SF12 = 12-item Short Form Health
Survey; TKA = total knee arthroplasty; WOMAC = Western Ontario and McMaster
Universities Arthritis Index.
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 nsuccessful IDPE and 2SR. Most interestingly, we found
u
no difference in any outcome when comparing the control
group with the successful IDPE group. These findings are
important when counselling a patient on the treatment
options available for an infected TKA. The improved satis
faction of a successful IDPE must be weighed against the
lower rates of successful eradication, and these issues need
to be discussed with the patient.
In our cohort, IDPE resulted in an eradication rate of
39%, which is consistent with rates reported in the litera
ture.6–10 Similarly, the eradication rate after 2SR in our
cohort was 87%, which is also consistent with published
rates.11–17 Treatment with IDPE is more likely to be suc
cessful in cases of acute postoperative and acute hemato
genous infections.19 The failed IDPE group in our study
had a greater proportion of acute hematogenous infection
than the successful IDPE group. It is possibile that some of
our patients in whom IPDE failed actually had misdiag
nosed chronic infections. However, the 39% eradication
rate in our study is consistent with that reported in previ
ous studies evaluating IDPE for infected TKAs.6–10 Fur
thermore, the main purpose of the present study was to
report on outcomes based on the treatment patients
received rather than the success or failure of eradication.
Limitations
The study limitations were as follows. First, this study
involved a retrospective review and was therefore subject
to all the biases associated with this type of study design.
Second, some patients in whom IDPE failed had been
referred from other hospitals. As the referring surgeons
followed IDPE treatment protocols similar to those at our
tertiary care centre, these patients were included in the
current study to maximize cohort size. Third, it should be
noted that there is a difference between the infected and
control cohorts with regards to mean duration of followup (64.2 mo in the infected cohorts v. 35.4 mo in the con
trol cohort). The control cohort was selected by matching
patients with noninfected primary TKAs with patients in
the infected cohort based on age and age-adjusted CCI
scores. This process resulted in a comparable control
cohort in terms of patient number, age, age-adjusted CCI
and body mass index. As a result of the matching process,
there was a difference in mean duration of follow-up
between the cohorts. However, since previous literature
has demonstrated that clinical outcome scores do not
change significantly beyond 18 months after surgery,29,30
the comparison of clinical outcomes in the cohorts is still
relevant despite the differential follow-up. Finally, the
data included in the current study depend on the quality
of the data recorded in the medical records and are there
fore subject to the limitations faced by many retrospective
cohort designs. In some cases the onset of symptoms were
not well recorded in terms of hours and/or days. There
406
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fore, although we could definitively identify that patients
fit our definition of acute symptoms (< 4 wk), in some
cases we were unable to reliably calculate an hour or day
value for onset of symptoms. As a result we have not pre
sented these data in our study.
The main strength of this study is that it offers a unique
look at a large patient cohort experiencing a difficult compli
cation after TKA. It also examines how different treatment
algorithms affect patient-reported outcomes and ROM after
treatment of infection. To our knowledge, patient-reported
outcomes have previously not been published in the litera
ture or been considered as part of the controversy regarding
the appropriate management of the infected TKA.

Conclusion
There may be a role for IDPE in the treatment of peripros
thetic infections owing to the potential for greater patient
satisfaction with IDPE than with 2SR. The improved satis
faction associated with a successful IDPE must be weighed
against its lower rate of successful eradication of infection.
By attempting to identify the patients in whom IDPE is
most likely to succeed, a surgeon can maximize patient out
comes when dealing with periprosthetic infection.
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